Etiology, Management, and Outcomes of Pediatric Telogen Effluvium: A Single-Center Study in the United States

    October 2022 in “ Pediatric Dermatology
    Vivien Chen, Lauren C. Strazzulla, Sara M. Asbeck, Fernanda Bellodi Schmidt
    Image of study
    TLDR Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.
    The study "Etiology, management, and outcomes of pediatric telogen effluvium: A single‐center study in the United States" conducted a retrospective analysis of 76 pediatric patients diagnosed with Telogen Effluvium (TE) from 2009 to 2021 at the University of Miami. TE is a type of non-scarring alopecia that causes rapid hair loss. The study found that 67% of patients (51 out of 76) had an identifiable trigger for their TE, with emotional stress and acute febrile illness being the most common, followed by nutritional deficiencies, specifically iron, ferritin, and vitamin D. The most common treatment approach was observation, and different treatments resulted in similar rates of improvement. The study concluded that there is a need for more evidence-based treatment approaches for pediatric TE.
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results

    Related Community Posts Join

    6 / 404 results

      community I’ve read multiple times that Fin increases hair quality… NOT for me!

      in Treatment  97 upvotes 1 year ago
      A user has been on finasteride for 6 months and feels their hair quality has worsened, experiencing more hair loss and scalp irritation. They are considering seeing a dermatologist, while others suggest the issue might be unrelated to finasteride, possibly due to deficiencies or other conditions.

      community My scalp punch biopsy results🤔?

      in Female  8 upvotes 1 year ago
      Female using Rogaine foam for hair loss had scalp punch biopsy, diagnosed with Androgenetic Alopecia (AGA). Doctor recommended starting Spironolactone 50mg.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Similar Research

    5 / 1000+ results
      Alopecia in General Medicine

      research Alopecia in General Medicine

      13 citations, February 2016 in “Clinical Medicine”
      The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.
      Acquired Scalp Alopecia: A Review

      research Acquired Scalp Alopecia: A Review

      44 citations, November 1998 in “Australasian Journal of Dermatology”
      Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.
      Telogen Effluvium: A Review

      research Telogen Effluvium: A Review

      70 citations, January 2015 in “Journal of Clinical and Diagnostic Research”
      Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.
      Hair and Systemic Disease

      research Hair and Systemic Disease

      58 citations, October 2001 in “Dermatologic Clinics”
      Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.